High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$3.1M
$3,060,070
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2026-03-04
$745,984x8
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2026-03-04 | $745,984x8 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2026-03-02
$523,584x10
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2026-03-02 | $523,584x10 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2026-02-13
$607,448
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2026-02-13 | $607,448 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2026-01-12
$547,927x21
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2026-01-12 | $547,927x21 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2025-10-02
$635,126x12
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2025-10-02 | $635,126x12 | S | Form 4 |